WPRIM Management System> DCMS> Blood Research> 2016> 51> 1

Volume: 51 Issue: 1

1. Combined factor V and VIII deficiency in a young woman with abundant bleeding after tooth extraction. Page:67—68
2. Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?. Page:66—66
3. Oligosecretory multiple myeloma: a case report. Page:63—65
4. A case of Pneumocystis jiroveci pneumonia after bendamustine-based chemotherapy for refractory diffuse large B-cell lymphoma. Page:61—63
5. Comparison of an international scale method and a log reduction method for monitoring of early molecular response in chronic myeloid leukemia patients. Page:58—61
6. Influence of genetic polymorphisms in the folate pathway on toxicity after high-dose methotrexate treatment in pediatric osteosarcoma. Page:50—57
7. Survey of experts on therapeutic policies and proposals for the optimal timing for allogeneic peripheral blood stem cell transplantation in transfusion-dependent patients with myelodysplastic syndrome-refractory anemia. Page:44—49
8. Long-term course of anti-factor VIII antibody in patients with hemophilia A at a single center. Page:37—43
9. Humanizing NOD/SCID/IL-2Rγnull (NSG) mice using busulfan and retro-orbital injection of umbilical cord blood-derived CD34+ cells. Page:31—36
10. Plasma cell leukemia in North India: retrospective analysis of a distinct clinicohematological entity from a tertiary care center and review of literature. Page:23—30
11. A scientific treatment approach for acute mast cell leukemia: using a strategy based on next-generation sequencing data. Page:17—22
12. Recent advances in haploidentical hematopoietic stem cell transplantation using ex vivo T cell-depleted graft in children and adolescents. Page:8—16
13. Extranasal natural killer/T-cell lymphoma initially presenting as myelofibrosis. Page:7—7
14. Waldenström macroglobulinemia presenting with neurological symptoms after chemotherapy. Page:6—6
15. Platelet-rich plasma: a healing virtuoso. Page:3—5
16. Application of next generation sequencing in the diagnosis and management of mast cell leukemia. Page:1—2